Survival associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small-cell lung cancer

References

• Cancer.org. What are the key statistics about lung cancer [Internet]. Atlanta, GA: American Cancer Society; 2016 Available from: http://www.cancer.org/cancer/lungcancer-non-smallcell/detailedguide/non-small-cell-lung-cancer-key-statistics. Accessed October 1, 2016.
   Google Scholar
• Lung.org. Trends in COPD morbidity and mortality [Internet]. Washington, DC: American Lung Association; 2013 Available from: http://www.lung.org/assets/documents/research/copd-trend-report.pdf. Accessed August 5, 2015.
   Google Scholar
• Ford ES, Croft JB, Mannino DM, Wheaton AG, Zhang X, Giles WH. COPD surveillance—United States, 1999–2011. Chest J. 2013;144(1):284–305. doi:10.1378/chest.13-0809
   PubMed Web of Science ®Google Scholar
• Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971–2000. Respir Care. 2002;47(10):1184–1199.12354338
   PubMedGoogle Scholar
• Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE; Lung Health Study Research Group. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005;142:233–239. doi:10.7326/0003-4819-142-4-200502150-0000515710956
   PubMed Web of Science ®Google Scholar
• Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009;34(2):380–386. doi:10.1183/09031936.0014420819196816
   PubMed Web of Science ®Google Scholar
• Wasswa-Kintu S, Gan WQ, Man SFP, Pare PD, Sin DD. Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax. 2005;60:570–575. doi:10.1136/thx.2004.03713515994265
   PubMed Web of Science ®Google Scholar
• Calabro E, Randi G, La Vecchia C, et al. Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes. Eur Respir J. 2010;35(6):146–151. doi:10.1183/09031936.0004990919679603
   PubMed Web of Science ®Google Scholar
• seer.cancer.gov. Overview of the SEER program [Internet]. Bethesda, MD: National Cancer Institute Available from: https://seer.cancer.gov/about/overview.html. Accessed February 2, 2015.
   Google Scholar
• Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. Eur J Cancer. 2009;45(5):747–755. doi:10.1016/j.ejca.2008.11.03219117750
   PubMed Web of Science ®Google Scholar
• Healthcaredelivery.cancer.gov. SEER-medicare: medicare claims files [Internet]. Bethesda, MD: National Cancer Institute Available from: https://healthcaredelivery.cancer.gov/seermedicare/medicare/claims.html. Accessed March 15, 2015.
   Google Scholar
• Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care. 1993;732–748.8336512
   PubMed Web of Science ®Google Scholar
• Simoni-Wastila L, Keri Yang HW, Blanchette CM, Zhao L, Qian J, Dalal AA. Hospital and emergency department utilization associated with treatment for chronic obstructive pulmonary disease in a managed-care Medicare population. Curr Med Res Opin. 2009;25(11):2729–2735. doi:10.1185/0300799090326715719778165
   PubMed Web of Science ®Google Scholar
• Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–619.1607900
   PubMed Web of Science ®Google Scholar
• Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53:1258–1267.11146273
   PubMed Web of Science ®Google Scholar
• Healthcaredelivery.cancer.gov. SEER-medicare: calculation of comorbidity weights [Internet]. Bethesda, MD: National Cancer Institute Available from: https://healthcaredelivery.cancer.gov/seermedicare/considerations/calculation.html. Accessed August 15, 2015.
   Google Scholar
• Shah S, Blanchette CM, Coyle JC, et al. Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC. J Med Econ. 2018;21(9):861–868. doi:10.1080/13696998.2018.148437029857784
   PubMed Web of Science ®Google Scholar
• Provencio M, Isla D, Sánchez A, Cantos B. Inoperable stage III non-small cell lung cancer: current treatment and role of vinorelbine. J Thorac Dis. 2011;3(3):197.22263088
   PubMedGoogle Scholar
• Cetin K, Ettinger DS, Hei YJ, O’Malley CD. Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results Program. Clin Epidemiol. 2011;3:139. doi:10.2147/CLEP.S1719121607015
   PubMedGoogle Scholar
• Kurishima K, Satoh H, Ishikawa H, et al. Lung cancer patients with chronic obstructive pulmonary disease. Oncol Rep. 2001;8:63–65.11115570
   PubMed Web of Science ®Google Scholar
• Sekine Y, Katsura H, Koh E, Hiroshima K, Fujisawa T. Early detection of COPD is important for lung cancer surveillance. Eur Res J. 2012;39(5):1230–1240. doi:10.1183/09031936.00126011
   Web of Science ®Google Scholar
• López-Encuentra A, Astudillo J, Cerezal J, Gonzalez-Aragoneses F, Novoa N, Sánchez-Palencia A. Prognostic value of chronic obstructive pulmonary disease in 2994 cases of lung cancer. Eur J Cardiothorac Surg. 2005;27(1):8–13.15736303
   PubMed Web of Science ®Google Scholar
• Sekine Y, Behnia M, Fujisawa T. Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC. Lung Cancer. 2002;37:95–101. doi:10.1016/S0169-5002(02)00014-412057873
   PubMed Web of Science ®Google Scholar
• Nakajima T, Sekine Y, Yamada Y, et al. Long-term surgical outcome in patients with lung cancer and coexisting severe COPD. Thorac Cardiovasc Surg. 2009;57:339–342. doi:10.1055/s-0029-118557119707975
   PubMed Web of Science ®Google Scholar
• Young RP, Hopkins RJ, Gamble GD, Etzel C, El-Zein R, Crapo JD. Genetic evidence linking lung cancer and COPD: a new perspective. Appl Clin Genet. 2011;4:99–111. doi:10.2147/TACG.S2008323776371
   PubMedGoogle Scholar
• Houghton AM, Mouded M, Shapiro SD. Common origins of lung cancer and COPD. Nat Med. 2008;14:1023–1024. doi:10.1038/nm1008-102318841139
   PubMed Web of Science ®Google Scholar
• Rama I, Griny ´ O JM. Malignancy after renal transplantation: the role of immunosuppression. Nat Rev Nephrol. 2010;6:511–519. doi:10.1038/nrneph.2010.10220736984
   PubMed Web of Science ®Google Scholar
• Bowman RV, Yang IA, Semmler AB, Fong KM. Epigenetics of lung cancer. Respirology. 2006;11:355–365. doi:10.1111/j.1440-1843.2006.00859.x16771905
   PubMed Web of Science ®Google Scholar
• Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest J. 2003;123:21S–49S. doi:10.1378/chest.123.1_suppl.21S
   PubMed Web of Science ®Google Scholar
• Gao Y, Goldstein AM, Consonni D, et al. Family history of cancer and nonmalignant lung diseases as risk factors for lung cancer. Int J Cancer. 2009;125:146–152. doi:10.1002/ijc.v125:119350630
   PubMed Web of Science ®Google Scholar
• Turner MC, Chen Y, Krewski D, Calle EE, Thun MJ. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med. 2007;176:285–290. doi:10.1164/rccm.200612-1792OC17478615
   PubMed Web of Science ®Google Scholar
• Yang P, Sun Z, Krowka MJ, et al. Alpha1- antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. Arch Intern Med. 2008;168:1097–1103. doi:10.1001/archinte.168.21.235518504338
   PubMed Web of Science ®Google Scholar
• Koshiol J, Rotunno M, Consonni D, et al. Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study. PLoS One. 2009;4(10):e7380. doi:10.1371/journal.pone.000738019812684
   PubMed Web of Science ®Google Scholar
• Prescott E, Lange P, Vestbo J. Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Res J. 1995;8(8):1333–1338. doi:10.1183/09031936.95.08081333
   PubMed Web of Science ®Google Scholar
• Tian PW, Wen FQ. Clinical significance of airway mucus hypersecretion in chronic obstructive pulmonary disease. J Transl Med. 2015;3(3):89–92. doi:10.1515/jtim-2015-0013
   Google Scholar
• Brenner DR, McLaughlin JR, Hung RJ. Previous lung diseases and lung cancer risk: a systematic review and meta-analysis. PLoS One. 2011;6:e17479. doi:10.1371/journal.pone.001747921483846
   PubMed Web of Science ®Google Scholar
• Wang H, Yang L, Zou L, et al. Association between chronic obstructive pulmonary disease and lung cancer: a case-control study in Southern Chinese and a meta-analysis. PLoS One. 2012;7(9):e46144. doi:10.1371/journal.pone.004309623029414
   PubMed Web of Science ®Google Scholar
• Bruse S, Petersen H, Weissfeld J, et al. Increased methylation of lung cancer-associated genes in sputum DNA of former smokers with chronic mucous hypersecretion. Respir Res. 2014;15(1):2. doi:10.1186/1465-9921-15-224405663
   PubMed Web of Science ®Google Scholar
• Leng S, Stidley CA, Willink R, et al. Double-strand break damage and associated DNA repair genes predispose smokers to gene methylation. Cancer Res. 2008;68(8):3049–3056. doi:10.1158/0008-5472.CAN-07-634418413776
   PubMed Web of Science ®Google Scholar
• Cuozzo C, Porcellini A, Angrisano T, et al. DNA damage, homology-directed repair, and DNA methylation. PLoS Genet. 2007;3(7):e110. doi:10.1371/journal.pgen.003011017616978
   PubMed Web of Science ®Google Scholar
• Tessema M, Yingling CM, Picchi MA, et al. Epigenetic repression of CCDC37 and MAP1B links chronic obstructive pulmonary disease to lung cancer. J Thorac Oncol. 2015;10(8):1181–1188. doi:10.1097/JTO.000000000000059226200272
   PubMed Web of Science ®Google Scholar
• de Oca MM, Halbert RJ, Lopez MV, et al. Chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study. Eur Res J. 2012;40(1):28–36.
   Web of Science ®Google Scholar
• Burgel PR, Nesme-Meyer P, Chanez P, et al. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest J. 2009;135(4):975–982. doi:10.1378/chest.08-2062
   PubMed Web of Science ®Google Scholar